Clinical Trial Update: Clock Proteins as Prognostic Markers

View source ↗

Summary

A clinical trial investigating clock proteins as prognostic markers in severe eosinophilic asthma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Medical University of Graz | Conditions: Severe Eosinophilic Asthma | Status: TERMINATED